Rutgers Institute for Information Policy and Law is pleased to announce the Lastowka Short-Form Writing Competition. Open to Rutgers students and recent graduates (class of 2015), the award will be given to an entry of 500-1,500 words on a topic of intellectual property or information policy more broadly. Professor Greg Lastowka (1968-2015) will be remembered … Continue reading Lastowka Writing Competition…
Category: News
Professor Goodman and RIIPL to Guide NJ Journalists on Digital Newsgathering Law
Professor Ellen P. Goodman is thrilled to announce the receipt of a grant from the Geraldine R. Dodge Foundation in support of a RIIPL project on digital journalism. The grant comes from the Foundation’s journalism sustainability project, with funding from the John S. and James L. Knight Foundation. Working with students, Goodman … Continue reading Professor Goodman and RIIPL to Guide NJ Journalists on Digital Newsgathering Law…
Prof. Carrier WSJ interview on EU charges against Google
Prof. Carrier was interviewed on Wall Street Journal TV about the European Union’s charges against Google for favoring its services over those of rivals.
New article on Loestrin pay-for-delay case
Issues of pay-for-delay settlements are percolating in the courts: California Supreme Court, 3rd Circuit, district courts. Next up: the the 1st Circuit, reviewing the dangerous Loestrin decision. In In re Loestrin 24 FE Antitrust Litigation, the U.S. District Court for the District of Rhode Island issued a concerning ruling on drug patent settlements. The court … Continue reading New article on Loestrin pay-for-delay case…
April 9 noon talk by Mark Warner on pharmaceutical industry
RIIPL is pleased to announce a lecture by Canadian expert and commentator Mark Warner on April 9 at noon at the law school. Mark Warner will speak about a range of current competition, trade, investment and IP issues involving the pharmaceutical industry in Canada and the implications for U.S. investors and policymakers. He will discuss … Continue reading April 9 noon talk by Mark Warner on pharmaceutical industry…